PVLA

142.8502.00%
WH

Wesley H. Kaupinen

Founder, President, CEO & Director

Mr. Wesley H. Kaupinen, also known as Wes, is Director of Primrose Bio, Inc. He serves as Chief Executive Officer, Director, Founder and President at Palvella Therapeutics, Inc. from December 2024. Mr. Kaupinen previously served as Legacy Palvella’s Chief Executive Officer and as a member of the Legacy Palvella board of directors since December 2015 until December 2024 and was further appointed President in August 2016. Mr. Kaupinen previously served on the board of directors of Biocoat Holdings, LLC and TELA Bio, Inc. Earlier in his career, Mr. Kaupinen also held commercial and general management positions at Johnson & Johnson Cordis Cardiology. He served as Senior Vice President of Corporate Development and Commercialization at Insmed Incorporated until July 2015. He served as Vice President of Corporate Development and Commercialization at Insmed Incorporated since August 2013. He served as a Principal of Quaker BioVentures since 2010. He joined Quaker BioVentures as a Senior Associate in January 2009. Previously, he held various roles in Sales Management, Sales Operations and Product Development in the U.S. Trauma Division of Synthes. While at Synthes, he worked on creating, launching and executing sales strategy. Prior to this, he worked with J&J Cordis Cardiology where he gained experience in marketing and medical device. He also worked at Apax Partners Worldwide LLP as the sole Investment Professional with a primary focus on specialty pharmaceutical and medical device investments. He joined Apax in 2002. He was Analyst of FleetBoston Robertson Stephens, Inc. He was an Associate at Apax Partners LLP and Apax Partners, Inc. Previously, he was an Investment Banking Analyst in the Life Sciences group at Robertson Stephens, Inc. While there, he focused on corporate finance, Merger and Acquisition and growth-oriented companies in the biotechnology, medical technology and specialty pharmaceutical industries. He is a Board Observer at NB Therapeutics, NovaSom and TransEnterix. He served as Director of Intact Vascular, Inc. He holds an M.B.A. from The Wharton School of the University of Pennsylvania, where he was the recipient of the William L. Kissick MD Scholarship Award and a B.A. in Economics from the University of Virginia.

Positions